GeoVax Labs, Inc. (GOVXW)
USD 0.1
(-25.85%)
USD 0.1
(-25.85%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -25.17 Million | -19.03 Million | -11.19 Million | -2.75 Million | -1.39 Million | -1.54 Million |
| Net Income | -25.96 Million | -14.02 Million | -18.57 Million | -2.95 Million | -2.37 Million | -2.56 Million |
| Depreciation & Amortization | 74.16 Thousand | 56.28 Thousand | 38.52 Thousand | 19.65 Thousand | 8350.00 | 19.8 Thousand |
| Deferred income taxes | 1228.01 Billion | -3.65 Million | - | - | 348.29 Thousand | - |
| Stock-based compensation | 1.07 Million | 902.07 Thousand | 369.98 Thousand | 64.46 Thousand | 327.5 Thousand | 469.72 Thousand |
| Change in working capital | -356 Thousand | -5.96 Million | 6.92 Million | -806.00 | 636.28 Thousand | 527.54 Thousand |
| Other non-cash items | -1228.01 Billion | 3.65 Million | 37.76 Thousand | 124.18 Thousand | -348.29 Thousand | 18.26 Thousand |
| Investing Cash Flow | -48.94 Thousand | -134.25 Thousand | -47.71 Thousand | -156.79 Thousand | -7606.00 | - |
| Investments in PPE | -48.94 Thousand | -134.25 Thousand | -47.71 Thousand | -156.79 Thousand | -7606.00 | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -48.94 Billion | -134.25 Billion | - | - | - | - |
| Financing Cash Flow | 4.06 Million | 35.35 Million | 12.78 Million | 12.5 Million | 1.42 Million | 1.49 Million |
| Debt repayment | - | - | -27.86 Thousand | -11.88 Thousand | -10.25 Thousand | -300 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -1000.00 | - | - | - |
| Common Stock Issuance | 4.06 Million | 27.72 Million | 9.4 Million | 11.15 Million | 1.44 Million | 1.19 Billion |
| Other Financing Activities | 4062.44 Billion | 7.62 Million | 3.4 Million | 1.36 Million | 1.42 Million | -1.18 Billion |
| Accounts receivables | - | 49 Thousand | 133.65 Thousand | -114.06 Thousand | 53.21 Thousand | -62.05 Thousand |
| Accounts payables | -1.22 Million | -2.68 Million | 6810.23 Billion | 137.95 Billion | 639.28 Thousand | 553.11 Million |
| Inventory | - | -49 Thousand | -133.65 Thousand | 114.06 Thousand | -53.21 Thousand | - |
| Other working capital | 872.01 Thousand | -3.27 Million | -6810.22 Billion | -137.95 Billion | -3000.00 | -552.59 Million |
| Cash at beginning of period | 27.61 Million | 11.42 Million | 9.88 Million | 283.34 Thousand | 259.7 Thousand | 312.72 Thousand |
| Cash at end of period | 6.45 Million | 27.61 Million | 11.42 Million | 9.88 Million | 283.34 Thousand | 259.7 Thousand |
| Capital Expenditure | -48.94 Thousand | -134.25 Thousand | -47.71 Thousand | -156.79 Thousand | -7606.00 | - |
| Effect of forex changes on cash | -21160.12 Billion | - | - | - | - | - |
| Net cash flow / Change in cash | -21.16 Million | 16.18 Million | 1.54 Million | 9.6 Million | 23.64 Thousand | -53.02 Thousand |
| Free Cash Flow | -25.22 Million | -19.16 Million | -11.24 Million | -2.9 Million | -1.4 Million | -1.54 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.06 Million | -5.85 Million | -7.59 Million | -25.96 Million | -8.4 Million | -5.92 Million |
| Depreciation & Amortization | 23.74 Thousand | 19.57 Thousand | 22.21 Thousand | 74.16 Thousand | 17.31 Thousand | 17.31 Thousand |
| Deferred income taxes | - | - | -1.41 Million | 1228.01 Billion | 2.66 Million | -757.69 Thousand |
| Stock-based compensation | 101.64 Thousand | 157.73 Thousand | 261.45 Thousand | 1.07 Million | 297.94 Thousand | 269.51 Thousand |
| Change in working capital | 2.99 Million | -10.91 Thousand | -2.96 Million | -356 Thousand | 2.99 Million | -396.35 Thousand |
| Other non-cash items | -2.81 Million | 412.86 Thousand | 1.41 Million | -1228.01 Billion | -2.66 Million | 757.69 Thousand |
| Investing Cash Flow | - | - | -18.94 Thousand | -48.94 Thousand | -6192.00 | -23.8 Thousand |
| Investments in PPE | -2.00 | - | -18.94 Thousand | -48.94 Thousand | -6192.00 | -23.8 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -48.94 Billion | -48.94 Billion | - | - |
| Financing Cash Flow | 2.73 Million | - | 4.06 Million | 4.06 Million | - | - |
| Debt repayment | -135 Thousand | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.59 Million | - | 4.06 Million | 4.06 Million | - | - |
| Other Financing Activities | 2.73 Million | - | 4062.44 Billion | 4062.44 Billion | - | - |
| Accounts receivables | -300.67 Thousand | - | - | - | - | - |
| Accounts payables | 2.96 Million | -215.97 Thousand | -3.56 Million | -1.22 Million | 2.99 Million | -453.54 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 337.06 Thousand | 205.06 Thousand | 592.59 Thousand | 872.01 Thousand | 1701.00 | 57.18 Thousand |
| Cash at beginning of period | 768.85 Thousand | 6.45 Million | 12.68 Million | 27.61 Million | 17.78 Million | 23.84 Million |
| Cash at end of period | 1.56 Million | 768.85 Thousand | 6.45 Million | 6.45 Million | 12.68 Million | 17.78 Million |
| Capital Expenditure | -2.00 | - | -18.94 Thousand | -48.94 Thousand | -6192.00 | -23.8 Thousand |
| Effect of forex changes on cash | - | - | 27612.7 Billion | -21160.12 Billion | - | - |
| Net cash flow / Change in cash | 792.85 Thousand | -5.68 Million | -6.23 Million | -21.16 Million | -5.1 Million | -6.06 Million |
| Free Cash Flow | -1.94 Million | -5.68 Million | -10.29 Million | -25.22 Million | -5.1 Million | -6.06 Million |
BRE
SAAFY
300207
AJB
OMER
301191